Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sensus Healthcare Inc | SRTS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.25 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.25 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.79 - 5.38 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 3.25 | USD |
Sensus Healthcare Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 54.06M | 16.38M | - | 24.41M | 485k | 0.03 | 111.49 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sensus Healthcare News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRTS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.17 | 3.5995 | 3.09 | 3.26 | 112,743 | 0.08 | 2.52% |
| 1 Month | 3.83 | 4.02 | 3.09 | 3.53 | 87,043 | -0.58 | -15.14% |
| 3 Months | 3.59 | 5.38 | 2.91 | 3.97 | 155,177 | -0.34 | -9.47% |
| 6 Months | 2.43 | 5.38 | 1.79 | 3.44 | 117,783 | 0.82 | 33.74% |
| 1 Year | 5.13 | 5.38 | 1.79 | 3.27 | 132,232 | -1.88 | -36.65% |
| 3 Years | 3.48 | 15.25 | 1.79 | 7.64 | 201,198 | -0.23 | -6.61% |
| 5 Years | 6.16 | 15.25 | 1.7603 | 6.91 | 154,389 | -2.91 | -47.24% |
Sensus Healthcare Description
| Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated primarily from customers in the United States. |
